Cargando…

A blood tumor marker combination assay produces high sensitivity and specificity for cancer according to the natural history

Diagnosis using a specific tumor marker is difficult because the sensitivity of this detection method is under 20%. Herein, a tumor marker combination assay, combining growth‐related tumor marker and associated tumor marker (Cancer, 73(7), 1994), was employed. This double‐blind tumor marker combinat...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kobayashi, Tsuneo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852360/ https://www.ncbi.nlm.nih.gov/pubmed/29464878 http://dx.doi.org/10.1002/cam4.1275

Ejemplares similares

The natural history of intravascular lymphomatosis
por: Fonkem, Ekokobe, et al.
Publicado: (2014)

Natural history of pain associated with melanoma surgery
por: Slagelse, Charlotte, et al.
Publicado: (2018)

Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes
por: Kessler, Tobias, et al.
Publicado: (2020)

Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer
por: Gargallo, Carla J., et al.
Publicado: (2018)

Serum exosomal microRNAs combined with alpha‐fetoprotein as diagnostic markers of hepatocellular carcinoma
por: Wang, Yurong, et al.
Publicado: (2018)

Tumor‐infiltrating CD8(+) T‐cell density is an independent prognostic marker for oral squamous cell carcinoma
por: Shimizu, Shota, et al.
Publicado: (2019)

Diagnostic approach using ERCP‐guided transpapillary forceps biopsy or EUS‐guided fine‐needle aspiration biopsy according to the nature of stricture segment for patients with suspected malignant biliary stricture
por: Lee, Yun Nah, et al.
Publicado: (2017)

Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening
por: Zhao, Guodong, et al.
Publicado: (2019)

Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma
por: Kim, Seung Hyun, et al.
Publicado: (2017)

TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity
por: Kaminski, Michael F, et al.
Publicado: (2022)

Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma
por: Chen, Zhongqing, et al.
Publicado: (2019)

Sponsorship of oncology clinical trials in the United States according to age of eligibility
por: Neel, Dylan V., et al.
Publicado: (2020)

Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer
por: Li, Yang, et al.
Publicado: (2019)

Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)
por: Hatch, Ace J., et al.
Publicado: (2016)

Analysis of prognostic factors for pancreatic head cancer according to para‐aortic lymph node
por: Lin, Jian‐yu, et al.
Publicado: (2016)

Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models
por: Balza, Enrica, et al.
Publicado: (2021)

Development of a prediction model with serum tumor markers to assess tumor metastasis in lung cancer
por: Wang, Jiasi, et al.
Publicado: (2020)

Blood functional assay for rapid clinical interpretation of germline TP53 variants
por: Raad, Sabine, et al.
Publicado: (2021)

Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer––Comparison with pathological risk factors according to the NCCN guidelines
por: Lee, Li‐Yu, et al.
Publicado: (2021)

Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
por: Rosner, Samuel, et al.
Publicado: (2018)

Molecular natural history of breast cancer: Leveraging transcriptomics to predict breast cancer progression and aggressiveness
por: Cook, Daniel J., et al.
Publicado: (2020)

Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas
por: Papp, Emoke, et al.
Publicado: (2020)

Survival following radiotherapy in young women with localized early‐stage breast cancer according to molecular subtypes
por: Liu, Qi‐Qi, et al.
Publicado: (2019)

The prognostic value of PD‐L1 expression in upper tract urothelial carcinoma varies according to platelet count
por: Miyama, Yu, et al.
Publicado: (2018)

Predictive role of diffusion‐weighted whole‐body MRI (DW‐MRI) imaging response according to MY‐RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry
por: Belotti, Angelo, et al.
Publicado: (2021)

Replication Study: Systematic identification of genomic markers of drug sensitivity in cancer cells
por: Vanden Heuvel, John P, et al.
Publicado: (2018)

MRI‐guided interventional natural killer cell delivery for liver tumor treatment
por: Su, Zhanliang, et al.
Publicado: (2018)

A novel dual‐marker expression panel for easy and accurate risk stratification of patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2018)

The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion
por: Gil, Juliana S., et al.
Publicado: (2013)

A hierarchical prognostic model for risk stratification in patients with early breast cancer according to (18)F‐fludeoxyglucose uptake and clinicopathological parameters
por: Cha, Jongtae, et al.
Publicado: (2018)

Stereotactic biopsy for adult brainstem lesions: A surgical approach and its diagnostic value according to the 2016 World Health Organization Classification
por: Jung, In‐Ho, et al.
Publicado: (2021)

Pilot study of combined FDG‐PET and dynamic contrast‐enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response
por: Banks, Thomas I., et al.
Publicado: (2018)

The clinical behavior and survival of patients with hepatocellular carcinoma and a family history of the disease
por: An, Jihyun, et al.
Publicado: (2019)

Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer
por: Pruitt, Sandi L., et al.
Publicado: (2021)

Prognostic significance of tumor-associated macrophages polarization markers in lung cancer: a pooled analysis of 5105 patients
por: Yi, Bin, et al.
Publicado: (2023)

Comparison of prognoses according to non‐positive and positive spectrin αII expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective study.
por: Maeda, Osamu, et al.
Publicado: (2016)

High expression of LEF1 correlates with poor prognosis in solid tumors, but not blood tumors: a meta-analysis
por: Yang, Xiaoqi, et al.
Publicado: (2020)

The Effects of smoking status and smoking history on patients with brain metastases from lung cancer
por: Shenker, Rachel F., et al.
Publicado: (2017)

Targeted RNA‐sequencing assays: a step forward compared to FISH and IHC techniques?
por: Tachon, Gaëlle, et al.
Publicado: (2019)

Smoking status combined with tumor mutational burden as a prognosis predictor for combination immune checkpoint inhibitor therapy in non‐small cell lung cancer
por: Sun, Li‐Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_srck2g8vsfb5e9cna0njitar8f